INTERNATIONAL BIOTECHNOLOGY TRUST PLC Holdings

INTERNATIONAL BIOTECHNOLOGY TRUST PLC is an investment fund managing more than 311.86M US dollars. The largest holdings include Horizon Therapeutics Public Limited Company, Seagen and Incyte. In Q3 2022 the fund bought assets of total value of 295.29M US dollars and sold assets of total value of 6.95M US dollars.

$311.85M

portfolio value

+3.03%

quarter

-20.20%

1 year

-0.46%

3 years

-45.59%

5 years

INTERNATIONAL BIOTECHNOLOGY TRUST PLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2017	82545000	37342000
Q2 2017	57495000	63546000
Q3 2017	65543000	66630000
Q4 2017	52859000	29663000
Q1 2018	49014000	68114000
Q2 2018	49717000	48281000
Q3 2018	55672000	106441000
Q4 2018	70432000	104022000
Q1 2019	103799000	12134000
Q2 2019	70623000	65189000
Q3 2019	12586000	51489000
Q4 2019	85764000	14957000
Q1 2020	30687000	82879000
Q2 2020	76755000	5164000
Q3 2020	39264000	28677000
Q4 2020	93051000	42918000
Q1 2021	115116000	92948000
Q2 2021	92183000	100127000
Q3 2021	116182000	87084000
Q4 2021	100886000	69065000
Q1 2022	56545000	120161000
Q2 2022	-481034	431306505
Q3 2022	295291067	6950472

INTERNATIONAL BIOTECHNOLOGY TRUST PLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 9.03% Portfolio value: 28.15M Avg. open price: $49.14 Current price: $104.85 P/L: +113.39% Bought +1885.48% shares Q3 2022	share	9.03%	28.15M	$49.14	$104.85	+113.39%	Bought +1885.48% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 7.29% Portfolio value: 22.73M Avg. open price: $155.82 Current price: $122.41 P/L: -21.44% Bought +1331.89% shares Q3 2022	share	7.29%	22.73M	$155.82	$122.41	-21.44%	Bought +1331.89% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 6.17% Portfolio value: 19.25M Avg. open price: $78.86 Current price: $83.13 P/L: +5.42% Bought +1498.36% shares Q3 2022	share	6.17%	19.25M	$78.86	$83.13	+5.42%	Bought +1498.36% shares Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 4.25% Portfolio value: 13.24M Avg. open price: $29.79 Current price: $26.09 P/L: -12.42% Bought +38938.84% shares Q3 2022	share	4.25%	13.24M	$29.79	$26.09	-12.42%	Bought +38938.84% shares Q3 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 4.13% Portfolio value: 12.88M Avg. open price: $62 Current price: $89.03 P/L: +43.60% Bought +2216.73% shares Q3 2022	share	4.13%	12.88M	$62	$89.03	+43.60%	Bought +2216.73% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 3.90% Portfolio value: 12.14M Avg. open price: $259.86 Current price: $298.9 P/L: +15.02% Bought +329.00% shares Q3 2022	share	3.90%	12.14M	$259.86	$298.9	+15.02%	Bought +329.00% shares Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 3.76% Portfolio value: 11.71M Avg. open price: $44.33 Current price: $60.48 P/L: +36.44% Bought +2350.44% shares Q3 2022	share	3.76%	11.71M	$44.33	$60.48	+36.44%	Bought +2350.44% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 3.30% Portfolio value: 10.30M Avg. open price: $49.15 Current price: $54.08 P/L: +10.02% Bought +6057.54% shares Q3 2022	share	3.30%	10.30M	$49.15	$54.08	+10.02%	Bought +6057.54% shares Q3 2022
Biotechnology uniQure N.V. Portfolio share: 3.27% Portfolio value: 10.20M Avg. open price: $25.44 Current price: $26.03 P/L: +2.33% Bought +6446.04% shares Q3 2022	share	3.27%	10.20M	$25.44	$26.03	+2.33%	Bought +6446.04% shares Q3 2022
Drug Manufacturers—Specialty & Generic Supernus Pharmaceuticals, Inc. Portfolio share: 3.23% Portfolio value: 10.07M Avg. open price: $29.97 Current price: $37.51 P/L: +25.17% Bought +3357.69% shares Q3 2022	share	3.23%	10.07M	$29.97	$37.51	+25.17%	Bought +3357.69% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 3.05% Portfolio value: 9.49M Avg. open price: $122.44 Current price: $96.25 P/L: -21.39% Bought +1389.43% shares Q3 2022	share	3.05%	9.49M	$122.44	$96.25	-21.39%	Bought +1389.43% shares Q3 2022
Biotechnology Exelixis, Inc. Portfolio share: 2.73% Portfolio value: 8.50M Avg. open price: $19.87 Current price: $17.39 P/L: -12.50% Bought +7348.56% shares Q3 2022	share	2.73%	8.50M	$19.87	$17.39	-12.50%	Bought +7348.56% shares Q3 2022
Biotechnology Regeneron Pharmaceuticals, Inc. Portfolio share: 2.47% Portfolio value: 7.71M Avg. open price: $363.15 Current price: $766.39 P/L: +111.04% Sold -20.06% shares Q3 2022	share	2.47%	7.71M	$363.15	$766.39	+111.04%	Sold -20.06% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.44% Portfolio value: 7.59M Avg. open price: $137.13 Current price: $234.4 P/L: +70.94% Bought +585.67% shares Q3 2022	share	2.44%	7.59M	$137.13	$234.4	+70.94%	Bought +585.67% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 2.31% Portfolio value: 7.19M Avg. open price: $78.49 Current price: $40.17 P/L: -48.82% Bought +1711.16% shares Q3 2022	share	2.31%	7.19M	$78.49	$40.17	-48.82%	Bought +1711.16% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 2.14% Portfolio value: 6.68M Avg. open price: $16.41 Current price: $23.56 P/L: +43.54% Bought +5623.71% shares Q3 2022	share	2.14%	6.68M	$16.41	$23.56	+43.54%	Bought +5623.71% shares Q3 2022
Biotechnology Vera Therapeutics, Inc. Portfolio share: 1.92% Portfolio value: 5.99M Avg. open price: $15.97 Current price: $16.3 P/L: +2.06% Bought +7253.12% shares Q3 2022	share	1.92%	5.99M	$15.97	$16.3	+2.06%	Bought +7253.12% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 1.75% Portfolio value: 5.45M Avg. open price: $50.03 Current price: $45.01 P/L: -10.03% Bought +9005.33% shares Q3 2022	share	1.75%	5.45M	$50.03	$45.01	-10.03%	Bought +9005.33% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 1.68% Portfolio value: 5.25M Avg. open price: $55.8 Current price: $40.45 P/L: -27.51% Bought +1693.19% shares Q3 2022	share	1.68%	5.25M	$55.8	$40.45	-27.51%	Bought +1693.19% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.59% Portfolio value: 4.97M Avg. open price: $89.86 Current price: $105.56 P/L: +17.47% Bought +788.59% shares Q3 2022	share	1.59%	4.97M	$89.86	$105.56	+17.47%	Bought +788.59% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 1.53% Portfolio value: 4.76M Avg. open price: $295.71 Current price: $218.76 P/L: -26.02% Bought +182.49% shares Q3 2022	share	1.53%	4.76M	$295.71	$218.76	-26.02%	Bought +182.49% shares Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 1.47% Portfolio value: 4.58M Avg. open price: $16.63 Current price: $5.38 P/L: -67.65% Bought +8307.79% shares Q3 2022	share	1.47%	4.58M	$16.63	$5.38	-67.65%	Bought +8307.79% shares Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 1.47% Portfolio value: 4.58M Avg. open price: $17.77 Current price: $20.08 P/L: +13.03% Bought +1918.65% shares Q3 2022	share	1.47%	4.58M	$17.77	$20.08	+13.03%	Bought +1918.65% shares Q3 2022
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 1.42% Portfolio value: 4.43M Avg. open price: $12.5 Current price: $11.9 P/L: -4.83% Bought +8957.39% shares Q3 2022	share	1.42%	4.43M	$12.5	$11.9	-4.83%	Bought +8957.39% shares Q3 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 1.38% Portfolio value: 4.31M Avg. open price: $14.29 Current price: $5.1 P/L: -64.31% Bought +9860.58% shares Q3 2022	share	1.38%	4.31M	$14.29	$5.1	-64.31%	Bought +9860.58% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 1.28% Portfolio value: 4.00M Avg. open price: $77.96 Current price: $53.81 P/L: -30.98% Bought +2379.20% shares Q3 2022	share	1.28%	4.00M	$77.96	$53.81	-30.98%	Bought +2379.20% shares Q3 2022
Drug Manufacturers—General Amgen Inc. Portfolio share: 1.17% Portfolio value: 3.66M Avg. open price: $221.41 Current price: $285.51 P/L: +28.95% Bought +63.85% shares Q3 2022	share	1.17%	3.66M	$221.41	$285.51	+28.95%	Bought +63.85% shares Q3 2022
Biotechnology Revance Therapeutics, Inc. Portfolio share: 1.04% Portfolio value: 3.24M Avg. open price: N/A Current price: $22.15 P/L: N/A N/A Q3 2022	share	1.04%	3.24M	N/A	$22.15	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 1.02% Portfolio value: 3.18M Avg. open price: $99.72 Current price: $126.81 P/L: +27.17% Bought +30.39% shares Q3 2022	share	1.02%	3.18M	$99.72	$126.81	+27.17%	Bought +30.39% shares Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 1.01% Portfolio value: 3.13M Avg. open price: $193.33 Current price: $278.55 P/L: +44.08% Bought +218.27% shares Q3 2022	share	1.01%	3.13M	$193.33	$278.55	+44.08%	Bought +218.27% shares Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 1.00% Portfolio value: 3.13M Avg. open price: $65.66 Current price: $77.5 P/L: +18.03% Bought +1422.84% shares Q3 2022	share	1.00%	3.13M	$65.66	$77.5	+18.03%	Bought +1422.84% shares Q3 2022
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 0.99% Portfolio value: 3.10M Avg. open price: N/A Current price: $11.17 P/L: N/A N/A Q3 2022	share	0.99%	3.10M	N/A	$11.17	N/A	N/A Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.97% Portfolio value: 3.03M Avg. open price: $109.52 Current price: $125.39 P/L: +14.49% Bought +975.74% shares Q3 2022	share	0.97%	3.03M	$109.52	$125.39	+14.49%	Bought +975.74% shares Q3 2022
Biotechnology Caribou Biosciences, Inc. Portfolio share: 0.87% Portfolio value: 2.71M Avg. open price: $5.43 Current price: $9.61 P/L: +76.98% Bought +18614.95% shares Q3 2022	share	0.87%	2.71M	$5.43	$9.61	+76.98%	Bought +18614.95% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.87% Portfolio value: 2.71M Avg. open price: $24.78 Current price: $20.91 P/L: -15.62% Bought +2989.10% shares Q3 2022	share	0.87%	2.71M	$24.78	$20.91	-15.62%	Bought +2989.10% shares Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.86% Portfolio value: 2.69M Avg. open price: $69.88 Current price: $36.59 P/L: -47.64% Bought +2785.89% shares Q3 2022	share	0.86%	2.69M	$69.88	$36.59	-47.64%	Bought +2785.89% shares Q3 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.78% Portfolio value: 2.43M Avg. open price: $69.5 Current price: $80.04 P/L: +15.17% Bought +1338.85% shares Q3 2022	share	0.78%	2.43M	$69.5	$80.04	+15.17%	Bought +1338.85% shares Q3 2022
Biotechnology Novavax, Inc. Portfolio share: 0.77% Portfolio value: 2.41M Avg. open price: $51.43 Current price: $16.52 P/L: -67.88% Bought +1844.53% shares Q3 2022	share	0.77%	2.41M	$51.43	$16.52	-67.88%	Bought +1844.53% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 0.73% Portfolio value: 2.29M Avg. open price: $162.36 Current price: $157.25 P/L: -3.15% Bought +541.07% shares Q3 2022	share	0.73%	2.29M	$162.36	$157.25	-3.15%	Bought +541.07% shares Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.72% Portfolio value: 2.23M Avg. open price: $60.77 Current price: $54.5 P/L: -10.32% Bought +1545.81% shares Q3 2022	share	0.72%	2.23M	$60.77	$54.5	-10.32%	Bought +1545.81% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 0.70% Portfolio value: 2.19M Avg. open price: N/A Current price: $19.26 P/L: N/A N/A Q3 2022	share	0.70%	2.19M	N/A	$19.26	N/A	N/A Q3 2022
Biotechnology BeiGene, Ltd. Portfolio share: 0.68% Portfolio value: 2.11M Avg. open price: $161.85 Current price: $201.86 P/L: +24.72% Bought +517.62% shares Q3 2022	share	0.68%	2.11M	$161.85	$201.86	+24.72%	Bought +517.62% shares Q3 2022
Biotechnology I-Mab Portfolio share: 0.65% Portfolio value: 2.02M Avg. open price: $13 Current price: $3.82 P/L: -70.61% Bought +8039.27% shares Q3 2022	share	0.65%	2.02M	$13	$3.82	-70.61%	Bought +8039.27% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.52% Portfolio value: 1.62M Avg. open price: $13.8 Current price: $17.98 P/L: +30.29% Bought +7161.83% shares Q3 2022	share	0.52%	1.62M	$13.8	$17.98	+30.29%	Bought +7161.83% shares Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.50% Portfolio value: 1.56M Avg. open price: $6.13 Current price: $6.75 P/L: +10.09% Bought +20315.28% shares Q3 2022	share	0.50%	1.56M	$6.13	$6.75	+10.09%	Bought +20315.28% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.50% Portfolio value: 1.55M Avg. open price: $55 Current price: $50.92 P/L: -7.42% Bought +15222.58% shares Q3 2022	share	0.50%	1.55M	$55	$50.92	-7.42%	Bought +15222.58% shares Q3 2022
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.43% Portfolio value: 1.34M Avg. open price: $4.21 Current price: $4.86 P/L: +15.44% Bought +7593.49% shares Q3 2022	share	0.43%	1.34M	$4.21	$4.86	+15.44%	Bought +7593.49% shares Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.43% Portfolio value: 1.34M Avg. open price: $51.76 Current price: $46.12 P/L: -10.90% Bought +1832.37% shares Q3 2022	share	0.43%	1.34M	$51.76	$46.12	-10.90%	Bought +1832.37% shares Q3 2022
Biotechnology Denali Therapeutics Inc. Portfolio share: 0.37% Portfolio value: 1.16M Avg. open price: $33.26 Current price: $32.63 P/L: -1.91% Bought +3298.93% shares Q3 2022	share	0.37%	1.16M	$33.26	$32.63	-1.91%	Bought +3298.93% shares Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.36% Portfolio value: 1.11M Avg. open price: $38.71 Current price: $46.82 P/L: +20.95% Bought +2482.42% shares Q3 2022	share	0.36%	1.11M	$38.71	$46.82	+20.95%	Bought +2482.42% shares Q3 2022
Biotechnology PTC Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 1.05M Avg. open price: $49.23 Current price: $42.06 P/L: -14.56% Bought +2394.06% shares Q3 2022	share	0.34%	1.05M	$49.23	$42.06	-14.56%	Bought +2394.06% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.32% Portfolio value: 1.00M Avg. open price: $13.76 Current price: $19.88 P/L: +44.48% Bought +7158.06% shares Q3 2022	share	0.32%	1.00M	$13.76	$19.88	+44.48%	Bought +7158.06% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.29% Portfolio value: 918K Avg. open price: $30.42 Current price: $38.89 P/L: +27.84% Bought +3194.57% shares Q3 2022	share	0.29%	918K	$30.42	$38.89	+27.84%	Bought +3194.57% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.28% Portfolio value: 864K Avg. open price: $28.82 Current price: $20.37 P/L: -29.33% Bought +4969.53% shares Q3 2022	share	0.28%	864K	$28.82	$20.37	-29.33%	Bought +4969.53% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 0.24% Portfolio value: 756K Avg. open price: N/A Current price: $41.39 P/L: N/A N/A Q3 2022	share	0.24%	756K	N/A	$41.39	N/A	N/A Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.23% Portfolio value: 718K Avg. open price: $10.58 Current price: $12.79 P/L: +20.89% Bought +9368.44% shares Q3 2022	share	0.23%	718K	$10.58	$12.79	+20.89%	Bought +9368.44% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 625K Avg. open price: $38.3 Current price: $76.9 P/L: +100.78% Bought +2516.82% shares Q3 2022	share	0.20%	625K	$38.3	$76.9	+100.78%	Bought +2516.82% shares Q3 2022
Drug Manufacturers—Specialty & Generic Ironwood Pharmaceuticals, Inc. Portfolio share: 0.20% Portfolio value: 621K Avg. open price: $11.53 Current price: $12.26 P/L: +6.33% Bought +8570.52% shares Q3 2022	share	0.20%	621K	$11.53	$12.26	+6.33%	Bought +8570.52% shares Q3 2022
Drug Manufacturers—Specialty & Generic HUTCHMED (China) Limited Portfolio share: 0.19% Portfolio value: 602K Avg. open price: $12.64 Current price: $13.5 P/L: +6.80% Bought +7816.18% shares Q3 2022	share	0.19%	602K	$12.64	$13.5	+6.80%	Bought +7816.18% shares Q3 2022
Biotechnology Allogene Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 539K Avg. open price: $11.4 Current price: $9.46 P/L: -17.02% Bought +8671.93% shares Q3 2022	share	0.17%	539K	$11.4	$9.46	-17.02%	Bought +8671.93% shares Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 0.17% Portfolio value: 536K Avg. open price: $11.04 Current price: $6.84 P/L: -38.04% Bought +1759.85% shares Q3 2022	share	0.17%	536K	$11.04	$6.84	-38.04%	Bought +1759.85% shares Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 370K Avg. open price: $18.99 Current price: $4.6 P/L: -75.78% Bought +5163.16% shares Q3 2022	share	0.12%	370K	$18.99	$4.6	-75.78%	Bought +5163.16% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 0.11% Portfolio value: 348K Avg. open price: $71.58 Current price: $80.16 P/L: +11.99% Bought +1296.87% shares Q3 2022	share	0.11%	348K	$71.58	$80.16	+11.99%	Bought +1296.87% shares Q3 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 0.10% Portfolio value: 312K Avg. open price: N/A Current price: $23.78 P/L: N/A N/A Q3 2022	share	0.10%	312K	N/A	$23.78	N/A	N/A Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.06% Portfolio value: 193K Avg. open price: N/A Current price: $18.89 P/L: N/A N/A Q3 2022	share	0.06%	193K	N/A	$18.89	N/A	N/A Q3 2022
BLACK DIAMOND THERAPEUTIC Portfolio share: 0.02% Portfolio value: 75K Avg. open price: N/A Current price: N/A P/L: N/A Bought +41021.50% shares Q3 2022	share	0.02%	75K	N/A	N/A	N/A	Bought +41021.50% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $76.98 Current price: $31.52 P/L: -59.06% Sold -100.00% shares Q3 2022	share	0.00%	0	$76.98	$31.52	-59.06%	Sold -100.00% shares Q3 2022
Biotechnology Intercept Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $14.62 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$14.62	N/A	Sold -100.00% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $46.83 Current price: $40.32 P/L: -13.91% Sold -100.00% shares Q3 2022	share	0.00%	0	$46.83	$40.32	-13.91%	Sold -100.00% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $236.82 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$236.82	N/A	Sold -100.00% shares Q3 2022
Biotechnology Genmab A/S Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $47.06 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$47.06	N/A	Sold -100.00% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $8.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$8.07	N/A	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $50.55 Current price: $51.99 P/L: +2.85% Sold -100.00% shares Q3 2022	share	0.00%	0	$50.55	$51.99	+2.85%	Sold -100.00% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $78 Current price: $48.93 P/L: -37.27% Sold -100.00% shares Q3 2022	share	0.00%	0	$78	$48.93	-37.27%	Sold -100.00% shares Q3 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $25.09 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$25.09	N/A	Sold -100.00% shares Q3 2022
Biotechnology BioNTech SE Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $169.74 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$169.74	N/A	Sold -100.00% shares Q3 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $16.04 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$16.04	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Avadel Pharmaceuticals plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.28 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.28	N/A	Sold -100.00% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $50.63 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$50.63	N/A	Sold -100.00% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $27.31 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$27.31	N/A	Sold -100.00% shares Q3 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.58 Current price: $12.7 P/L: +47.94% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.58	$12.7	+47.94%	Sold -100.00% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $65 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$65	N/A	Sold -100.00% shares Q3 2022
Biotechnology Gamida Cell Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.55 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.55	N/A	Sold -100.00% shares Q3 2022
Biotechnology Immunovant, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $14.68 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$14.68	N/A	Sold -100.00% shares Q3 2022

Showing TOP 84 INTERNATIONAL BIOTECHNOLOGY TRUST's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of INTERNATIONAL BIOTECHNOLOGY TRUST PLC?

The biggest position of the INTERNATIONAL BIOTECHNOLOGY TRUST PLC is Horizon Therapeutics Public Limited Company (HZNP) with 9.03% portfolio share worth of 28.16M US dollars.

Top 5 INTERNATIONAL BIOTECHNOLOGY TRUST's holdings represent 30.87% of the portfolio:

Horizon Therapeutics Public Limited Company (HZNP) – 9.03%
Seagen Inc. (SGEN) – 7.29%
Incyte Corporation (INCY) – 6.17%
Alkermes plc (ALKS) – 4.25%
Gilead Sciences, Inc. (GILD) – 4.13%

Who is the portfolio manager of INTERNATIONAL BIOTECHNOLOGY TRUST PLC?

The portfolio manager of the INTERNATIONAL BIOTECHNOLOGY TRUST PLC is .

What is the total asset value of the INTERNATIONAL BIOTECHNOLOGY TRUST PLC portfolio?

INTERNATIONAL BIOTECHNOLOGY TRUST PLC total asset value (portfolio value) is 311.86M US dollars.

Who is ?

is the portfolio manager of the INTERNATIONAL BIOTECHNOLOGY TRUST PLC.

What is (INTERNATIONAL BIOTECHNOLOGY TRUST PLC) fund performance?

INTERNATIONAL BIOTECHNOLOGY TRUST's quarterly performance is +3.03%, annualy -20.20%. In the past 3 years, the value of 's portfolio has decreased by -0%. In the past 5 years, the value of the portfolio has decreased by -46%.

What is the INTERNATIONAL BIOTECHNOLOGY TRUST PLC CIK?

INTERNATIONAL BIOTECHNOLOGY TRUST's Central Index Key is 0000942257 .

INTERNATIONAL BIOTECHNOLOGY TRUST PLC Holdings

INTERNATIONAL BIOTECHNOLOGY TRUST PLC portfolio value:

INTERNATIONAL BIOTECHNOLOGY TRUST PLC quarter portfolio value change:

INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1 year portfolio value change:

INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3 years portfolio value change:

INTERNATIONAL BIOTECHNOLOGY TRUST PLC 5 years portfolio value change: